IL6 and breast benign neoplasm: As the STAT3 protein is a key transcriptional regulatory factor in the IL-6 signaling pathway, whether this finding suggests that IL-6 is involved in the formation of GLM and benign breast tumors and whether there is a difference in the roles of IL-6 in these two diseases were the main objectives of the present study.